Association of GCLC rs600033 polymorphism with acute exacerbation phenotypes in COPD
Öz
Purpose: Chronic Obstructive Pulmonary Disease (COPD) is characterized by an imbalance between oxidative stress and antioxidant defense. Cellular senescence exacerbates this imbalance by impairing glutathione (GSH) synthesis, in which the glutamate-cysteine ligase catalytic subunit (GCLC) is the rate-limiting enzyme. This exploratory, hypothesis-generating study evaluated the association between the GCLC rs600033 G>C polymorphism and acute exacerbations of COPD (AECOPD) in a Turkish cohort.
Materials and Methods: A total of 117 COPD patients (59 stable, 58 with acute exacerbations) and 115 healthy controls were included. Genotype and allele frequencies were compared between groups, and multivariable models adjusting for age, sex, smoking, and FEV1 assessed exacerbation risk; p-values were corrected for multiple testing.
Results: No significant association was found between rs600033 G>C and overall COPD susceptibility, nor between stable COPD and AECOPD. The CC genotype was nominally more frequent in healthy controls than in AECOPD patients (OR=2.28, 95% CI: 1.04-5.00), but this association did not remain significant after correction for multiple testing. Predicted AECOPD probability increased with age, but the age × genotype interaction was not significant, and neither age nor genotype remained significant in the adjusted model. Adding genotype did not significantly improve model discrimination.
Conclusion: The GCLC rs600033 polymorphism showed only a nominal, unadjusted association with AECOPD that did not withstand correction for multiple testing or covariate adjustment. These exploratory findings do not support an independent role for this polymorphism in COPD exacerbation risk and require validation in larger cohorts.
Anahtar Kelimeler
Chronic Obstructive Pulmonary Disease, Cellular Aging, GCLC
Proje Numarası
23-KAEK-158
Etik Beyan
Ethical approval for this study was obtained from the Tokat Gaziosmanpaşa University Clinical Research Ethics Committee on July 13, 2023 (Approval No: 23-KAEK-158). Written informed consent was obtained from all participants.
Kaynakça
- Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347-65.
- Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385:899-909.
- Siedlinski M, Postma DS, van Diemen CC, Blokstra A, Smit HA, Boezen HM. Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes. Am J Respir Crit Care Med. 2008;178:13-9.
- Raghu G, Berk M, Campochiaro PA, Jaeschke H, Marenzi G, Richeldi L, et al. The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress. Curr Neuropharmacol. 2021;19:1202-24.
- Wei Y, Giunta S, Xia S. Hypoxia in aging and aging-related diseases: mechanism and therapeutic strategies. Int J Mol Sci. 2022;23:8165.
- Labarrere CA, Kassab GS. Glutathione: a Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation. Front Nutr. 2022;9:1007816.
- Nichenametla SN, Ellison I, Calcagnotto A, Lazarus P, Muscat JE, Richie JP Jr. Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase. Free Radic Biol Med. 2008;45:645-50.
- Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30:1-12.
- Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med. 2009;30:86-98.
- Ferguson G, Bridge W. Glutamate cysteine ligase and the age-related decline in cellular glutathione: the therapeutic potential of γ-glutamylcysteine. Arch Biochem Biophys. 2016;593:12-23.
